(Q43531971)

English

RAS testing of colorectal carcinoma—a guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Group

scientific article published in September 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

RAS testing of colorectal carcinoma—a guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

0 references

William G. Newman

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Emily Clare Shaw

8

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Salvador J Diaz-Cano

object named as

Salvador J Diaz-Cano

5

0 references

author name string

Newton A C S Wong

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

David Gonzalez

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Manuel Salto-Tellez

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Rachel Butler

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Mohammad Ilyas

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Philippe Taniere

9

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Shaun V Walsh

10

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Association of Clinical Pathologists Molecular Pathology and Diagnostics Group

11

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

1 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Journal of Clinical Pathology

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

67

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

751-757

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

The pattern of recurrent colorectal cancer in a prospective randomised study and the characteristics of diagnostic tests

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Validation of KRAS testing for anti-EGFR therapeutic decisions for patients with metastatic colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

KRAS mutations testing in colorectal carcinoma patients in Italy: from guidelines to external quality assessment

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Concordant KRAS mutations in primary and metastatic colorectal cancer tissue specimens: a meta-analysis and systematic review

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

The utility of diagnostic biopsy specimens for predictive molecular testing in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Intra-tumoral heterogeneity of KRAS and BRAF mutation status in patients with advanced colorectal cancer (aCRC) and cost-effectiveness of multiple sample testing.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Dynamics of cancer cell subpopulations in primary and metastatic colorectal tumors

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

KRAS mutations detected by the amplification refractory mutation system-Scorpion assays strongly correlate with therapeutic effect of cetuximab

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Low percentage of KRAS mutations revealed by locked nucleic acid polymerase chain reaction: implications for treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Should oncologists be aware in their clinical practice of KRAS molecular analysis?

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Preparing pathology for personalized medicine: possibilities for improvement of the pre-analytical phase.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Effect of fixatives and tissue processing on the content and integrity of nucleic acids

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

A high frequency of sequence alterations is due to formalin fixation of archival specimens

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

The effects of tissue fixation alternatives on DNA content: a study on normal colon tissue

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Molecular genetics external quality assessment pilot scheme for KRAS analysis in metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

A multicenter blinded study to evaluate KRAS mutation testing methodologies in the clinical setting

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Comparison of COBAS 4800 KRAS, TaqMan PCR and high resolution melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin embedded colorectal carcinomas.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs and beyond.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

A standardized framework for the validation and verification of clinical molecular genetic tests

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Genetic pathways in colorectal and other cancers

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202467

21 January 2018

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE11156

Identifiers

10.1136/JCLINPATH-2014-202467

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43531971&oldid=2098142502"